Other Receivables

Other receivables were comprised as follows:

Other Receivables

 

 

Dec. 31, 2016

 

Dec. 31, 2017

 

 

Total

 

Of which current

 

Total

 

Of which current

 

 

€ million

 

€ million

 

€ million

 

€ million

Other tax receivables

 

764

 

746

 

554

 

541

Deferred charges

 

549

 

358

 

298

 

192

Reimbursement claims

 

120

 

104

 

85

 

71

Net defined benefit asset

 

26

 

 

36

 

Receivables from employees

 

50

 

49

 

47

 

46

Miscellaneous receivables

 

1,284

 

953

 

656

 

426

Total

 

2,793

 

2,210

 

1,676

 

1,276

The reimbursement claims of €85 million (2016: €120 million) predominantly consisted of receivables from insurance companies in connection with product liability claims.

In 2016, miscellaneous receivables included a €441 million receivable from Dow AgroSciences LLC, United States, for damages and royalty payments resulting from the infringement of Bayer’s rights to the LibertyLink™ weed control system. This receivable was settled in May 2017.

Other receivables included €426 million (2016: €690 million) in financial receivables. Of this amount, receivables of €383 million (2016: €612 million) were neither impaired nor past due. Receivables of €26 million (2016: €50 million) were due immediately or up to three months past due. Receivables of €17 million (2016: €27 million) were more than three months past due.

Other receivables are stated net of impairment losses of €70 million (2016: €56 million), of which €67 million (2016: €52 million) related to a receivable from the Venezuelan exchange control authority reflecting the right to receive U.S. dollars at a preferential rate.

Compare to Last Year